Comparison of the effectiveness of three different skin substitutes for the treatment of pediatric burns
- PMID: 39671108
- DOI: 10.1007/s00431-024-05916-6
Comparison of the effectiveness of three different skin substitutes for the treatment of pediatric burns
Abstract
Early debridement of partial-thickness burns and coverage with skin substitutes is currently the standard of care in children, although there is currently no "gold standard" skin substitute. Our aim is to compare the effectiveness of three different skin substitutes, analyzing the medium- and long-term outcomes.
Methods: A retrospective study was conducted on burn patients under 18 years admitted to our Burn Unit between 2015 and 2021, who were divided into 3 groups according to the type of skin substitute used (EZ-derm®, Biobrane®, and Suprathel®). Demographic and clinical data and short- and long-term outcomes were analyzed. Effectiveness was analyzed by escharectomy and grafting rate during acute management and long-term follow-up reintervention rate. A total of 378 patients were included (179 EZ-derm® group, 107 Biobrane® group, and 92 Suprathel® group). No differences in demographics or burn characteristics were observed between the groups. Patients treated with Suprathel® had a significantly shorter hospital stay (median 4 days (IQR 2-9)), a lower rate of escharectomy and grafting during acute management (21.1%), and a lower long-term follow-up reintervention rate (18.5%) when compared to the EZ-derm® group (median stay 9 days (IQR 6-13); escharectomy and graft 24.6% and reintervention 26.8%) and to the Biobrane® group (median stay 9 days (IQR 7-14); escharectomy and graft 32.1% and reintervention 26.2%).
Conclusion: Treatment of partial-thickness burns with Suprathel® is associated with a shorter hospital stay, lower need for escharectomy and grafting, and lower need for long-term reintervention. Therefore, it should be considered the treatment of choice for pediatric partial-thickness burns.
What is known: • Different types of skin substitutes are available for the treatment of skin burns in paediatric patients.
What is new: • Suprathel® is linked to a reduction in hospital stays, a lower need for escharectomy and grafting, and a lower likelihood of requiring long-term re-interventions.
Keywords: Children; Hospital stay; Partial-thickness burns; Skin substitute.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval: The protocol of the study obtained the approval of La Paz Hospital Institutional Review Board (IRB number PI-5041) and complied with the guidelines of the Declaration of Helsinki (as revised in 2013). Conflict of interest: The authors declare no competing interests.
Similar articles
-
Biobrane dressing for paediatric burns in Singapore: a retrospective review.Singapore Med J. 2018 Jul;59(7):360-365. doi: 10.11622/smedj.2017116. Epub 2018 Jan 3. Singapore Med J. 2018. PMID: 29297087 Free PMC article.
-
Effectiveness of Suprathel® application in partial thickness burns, frostbites and Lyell syndrome treatment.Pol Przegl Chir. 2011 Oct;83(10):541-8. doi: 10.2478/v10035-011-0086-5. Pol Przegl Chir. 2011. PMID: 22189281
-
A clinical evaluation of Biobrane(®) and Suprathel(®) in acute burns and reconstructive surgery.Burns. 2011 Dec;37(8):1343-8. doi: 10.1016/j.burns.2011.07.010. Epub 2011 Aug 17. Burns. 2011. PMID: 21852044
-
Preliminary results in single-step wound closure procedure of full-thickness facial burns in children by using the collagen-elastin matrix and review of pediatric facial burns.Burns. 2015 Sep;41(6):1268-74. doi: 10.1016/j.burns.2015.01.007. Epub 2015 Feb 21. Burns. 2015. PMID: 25716758 Review.
-
Topical treatment for facial burns.Cochrane Database Syst Rev. 2020 Jul 29;7(7):CD008058. doi: 10.1002/14651858.CD008058.pub3. Cochrane Database Syst Rev. 2020. PMID: 32725896 Free PMC article.
Cited by
-
Metabolic and Hormonal Changes in Pediatric Burn Patients: Mechanisms, Evidence, and Care Strategies.Eur Burn J. 2025 Apr 7;6(2):17. doi: 10.3390/ebj6020017. Eur Burn J. 2025. PMID: 40265372 Free PMC article. Review.
References
-
- Guldogan CE, Kendirci M, Tikici D, Gundogdu E, Yastı AC (2017) Clinical infection in burn patients and its consequences. Ulus Travma Acil Cerrahi Derg 23:466–471 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical